Trial Profile
Dronedarone in Pacemaker Patients With Paroxysmal Atrial Fibrillation.
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 20 Jan 2020
Price :
$35
*
At a glance
- Drugs Dronedarone (Primary)
- Indications Paroxysmal atrial fibrillation
- Focus Therapeutic Use
- Acronyms DROPPAF
- 05 Apr 2012 European Clinical Trials Database reports actual initiation date as 2 Jul 2010.
- 28 Mar 2012 Status changed from not yet recruiting to recruiting as reported by European Clinical Trials Database record.
- 24 Feb 2010 New trial record